Bigul

Gold Coin Health Foods Ltd - 538542 - Board Meeting Intimation for Approve And Take On Record The Audited Standalone Financial Results Of The Company Under Indian Accounting Standards (Ind AS) For The Fourth Quarter And Year Ending On March 31, 2023

Gold Coin Health Foods Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve and take on record the audited standalone financial results of the Company under Indian Accounting Standards (Ind AS) for the fourth Quarter and Year ending on March 31, 2023; Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from April 01, 2023 till the expiry of 48 hours from the date the said financial results are made public.
17-05-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Change In Company Official Website URL

Please note that the company's official website url has been changed from 'https://www.goldcoinhealthfoods.com' to 'https://www.goldcoinhealthfoods.in'. Kindy take the above submission on record.
29-04-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Compliance Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015.

With reference to the above we are enclosing certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for period commencing from 1st April, 2022 to 31st March, 2023. Kindly acknowledge the receipt of above as due compliance of aforsaid regulation.
14-04-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (LODR), Regulations, 2015.

With reference to above we are enclosing herewith certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly acknowledge the receipt of above as due compliance of aforesaid regulation.
12-04-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from Accurate Securities & Registry Private Limited, the Registrar and Transfer Agent of the Company for the period ended on 31st December, 2022. Kindly acknowledge the same as due compliance of Listing Agreement.
12-04-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGold Coin Health Foods Ltd 2CIN NO.L15419GJ1989PLC012041 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Niraj Baid Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Pravinaben Gohil Designation: Whole Time Director And CFO EmailId: [email protected] Date: 10/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
10-04-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform that the trading window for dealing in Equity Shares of the Company by the insiders covered under Company's Code of Internal Procedure and Conduct for Prevention of Insider Trading of Securities is closed from Saturday, 1st April, 2023 till 48 hours after the declaration and publication of Audited Financial Results for the quarter and year ended 31st March, 2023.
31-03-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Board Meeting Outcome for Revised Outcome

Revised outcome Pursuant to second provision to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 7th February, 2023 at the Registered Office of the Company, which commenced at 3:30 P.M. and concluded at 4:00 P.M. inter-alia, has Consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Months ended on 31st December, 2022 along with Limited Review Report.
09-02-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Board Meeting Outcome for Outcome Of Board Meeting 7Th February, 2023.

The Board of Directors of the Company have transacted the following business in their Board Meeting held on 7th February, 2023. a) Considered and taken on record the Unaudited Standalone Results of the Company for the quarter ended and nine months ended on 31st December, 2022. b) Considered and taken limited review report. Kindly acknowledge the receipt of this letter with due compliance of SEBI (LODR) Regulations, 2015.
07-02-2023
Bigul

Gold Coin Health Foods Ltd - 538542 - Board Meeting Intimation for Intimation Of Board Meeting

Gold Coin Health Foods Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 ,inter alia, to consider and approve Pursuant to Regulations 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 7, 2023 inter alia to: 1) Approve and take on record the unaudited standalone financial results of the Company under Indian Accounting Standards (Ind AS) for the Quarter ending December 31, 2022; Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from January 01, 2023 till the expiry of 48 hours from the date the said financial results are made public.
01-02-2023
Next Page
Close

Let's Open Free Demat Account